GR3018675T3 - Antibodies to Promoters of colony stimulating factor activity. - Google Patents

Antibodies to Promoters of colony stimulating factor activity.

Info

Publication number: GR3018675T3
Authority: GR; Greece
Prior art keywords: promoters; stimulating factor; colony stimulating; factor activity; antibodies
Prior art date: 1989-07-10

Application number

GR960400074T

Other languages

English (en)

Inventor

Stephen D Wolpe

Anthony Cerami

Barbara Sherry

Original Assignee

Univ Rockefeller

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-10

Filing date

1996-01-16

Publication date

1996-04-30

1996-01-16 Application filed by Univ Rockefeller filed Critical Univ Rockefeller

1996-04-30 Publication of GR3018675T3 publication Critical patent/GR3018675T3/el

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Physics & Mathematics (AREA)
Developmental Biology & Embryology (AREA)
Physiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Analytical Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
General Engineering & Computer Science (AREA)

GR960400074T 1989-07-10 1996-01-16 Antibodies to Promoters of colony stimulating factor activity. GR3018675T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37793789A	1989-07-10	1989-07-10
PCT/US1990/003853 WO1991000919A1 (en)	1989-07-10	1990-07-10	Promoters of colony stimulating factor activity

Publications (1)

Publication Number	Publication Date
GR3018675T3 true GR3018675T3 (en)	1996-04-30

Family

ID=23491090

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960400074T GR3018675T3 (en)	1989-07-10	1996-01-16	Antibodies to Promoters of colony stimulating factor activity.

Country Status (12)

Country	Link
EP (1)	EP0409040B1 (el)
JP (1)	JPH04501860A (el)
AT (1)	ATE129158T1 (el)
AU (1)	AU638473B2 (el)
CA (1)	CA2035861A1 (el)
DE (1)	DE69023060T2 (el)
DK (1)	DK0409040T3 (el)
ES (1)	ES2088925T3 (el)
GR (1)	GR3018675T3 (el)
IE (1)	IE72139B1 (el)
PT (1)	PT94641A (el)
WO (1)	WO1991000919A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5145676A (en) *	1981-09-08	1992-09-08	The Rockefeller University	Method and agents for promoting wound healing
US5154921A (en) *	1990-07-13	1992-10-13	Dana-Farber Cancer Institute, Inc.	Promotion of maturation of hematopoietic progenitor cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1208546A (en) *	1981-09-08	1986-07-29	Anthony Cerami	Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
ATE149176T1 (de) *	1987-10-02	1997-03-15	Univ Rockefeller	Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta)
ATE154364T1 (de) *	1988-09-02	1997-06-15	Univ Rockefeller	Makrophagenabgeleiteter entzündungsmediator(mip- 2)

1990
- 1990-07-09 PT PT94641A patent/PT94641A/pt not_active Application Discontinuation
- 1990-07-09 ES ES90113097T patent/ES2088925T3/es not_active Expired - Lifetime
- 1990-07-09 IE IE248690A patent/IE72139B1/en not_active IP Right Cessation
- 1990-07-09 DK DK90113097.1T patent/DK0409040T3/da active
- 1990-07-09 AT AT90113097T patent/ATE129158T1/de not_active IP Right Cessation
- 1990-07-09 EP EP90113097A patent/EP0409040B1/en not_active Expired - Lifetime
- 1990-07-09 DE DE69023060T patent/DE69023060T2/de not_active Expired - Fee Related
- 1990-07-10 AU AU60402/90A patent/AU638473B2/en not_active Ceased
- 1990-07-10 CA CA002035861A patent/CA2035861A1/en not_active Abandoned
- 1990-07-10 WO PCT/US1990/003853 patent/WO1991000919A1/en not_active Ceased
- 1990-07-10 JP JP2510403A patent/JPH04501860A/ja active Pending
1996
- 1996-01-16 GR GR960400074T patent/GR3018675T3/el unknown

Also Published As

Publication number	Publication date
CA2035861A1 (en)	1991-01-11
PT94641A (pt)	1991-04-18
ES2088925T3 (es)	1996-10-01
DE69023060T2 (de)	1996-04-18
ATE129158T1 (de)	1995-11-15
JPH04501860A (ja)	1992-04-02
EP0409040B1 (en)	1995-10-18
DE69023060D1 (de)	1995-11-23
AU6040290A (en)	1991-02-06
WO1991000919A1 (en)	1991-01-24
DK0409040T3 (da)	1995-12-27
AU638473B2 (en)	1993-07-01
EP0409040A1 (en)	1991-01-23
IE72139B1 (en)	1997-03-26

Similar Documents

Publication	Publication Date	Title
WO1992013553A3 (en)	1992-09-17	Method and agents for promoting wound healing
CA2006473A1 (en)	1990-06-23	Improved anti-infective therapy
DE69024369D1 (de)	1996-02-01	Latenz assoziierte peptide und deren verwendung
CA2157927A1 (en)	1994-09-15	Therapeutic uses of bactericidal/permeability increasing protein produc ts
WO1996034953A3 (en)	1996-12-05	Cd16-ii variants
IL93508A0 (en)	1990-11-29	Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
IL125282A (en)	2003-06-24	Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
NZ228564A (en)	1991-06-25	Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
NZ504026A (en)	2002-12-20	Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
HUP9902429A2 (hu)	1999-10-28	TNF-receptor-asszociált faktor (TRAF) modulátorok előállítása és alkalmazása
FR2525604B2 (fr)	1985-06-07	Acides aza bicyclo heptane carboxyliques substitues, leur preparation et leur application en therapeutique
HUP9903921A2 (hu)	2000-03-28	Tumor nekrózis faktorral rokon ligandum
DE69534180D1 (de)	2005-06-02	Promotor der tie rezeptor protein kinase
DE69034112D1 (de)	2003-11-27	Antikörper gegen Lymphozyten-assoziiertes Zelloberflächenprotein
EP0310136A3 (en)	1990-03-07	Macrophage-derived inflammatory mediator (mip-1alpha and mip-1beta)
Seckinger et al.	1990	Tumor necrosis factor inhibitor: purification, NH2− terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities
IL88971A0 (en)	1989-08-15	Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
UA27055C2 (uk)	2000-02-28	Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
BG101126A (en)	1997-09-30	The use of muramylpeptide compounds
ES2107414T3 (es)	1997-12-01	Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
WO1999055861A3 (en)	2000-04-20	Fibroblast growth factor mutein compositions and methods of use therefor
Schmidinger et al.	2000	Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
DK0409040T3 (da)	1995-12-27	Kolonistimulerende faktoraktivitetspromotorer
JPS6438100A (en)	1989-02-08	Vascular endothelial cell growth factor
FR2568879B1 (fr)	1986-12-12	Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique